Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Safety and efficacy of CRISPR-mediated genome ablation of VEGFA as a treatment for choroidal neovascularization in nonhuman primate eyes

27 Sept 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Retinal Development and Disorders
Share to Retinal Diseases and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39342431
DOI: 10.1016/j.ymthe.2024.09.027

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Safety and efficacy of CRISPR-mediated genome ablation of VEGFA as a treatment for choroidal neovascularization in nonhuman primate eyesPMID 39342431Read ↗

CRISPR Technology for Ocular AngiogenesisSemantic proximity Read ↗

Factors Impacting Efficacy of AAV-Mediated CRISPR-Based Genome Editing for Treatment of Choroidal NeovascularizationSemantic proximity Read ↗

Genome Editing VEGFA Prevents Corneal Neovascularization In VivoSemantic proximity Read ↗

The application and progression of CRISPR/Cas9 technology in ophthalmological diseasesSemantic proximity Read ↗

Genome editing abrogates angiogenesis in vivoSemantic proximity Read ↗

Targeting vascular endothelial growth factor using retinal gene therapySemantic proximity Read ↗

CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degenerationSemantic proximity Read ↗

Characterisation of RNA editing and gene therapy with a compact CRISPR-Cas13 in the retinaSemantic proximity Read ↗

CRISPR/Cas9 mediated specific ablation of vegfa in retinal pigment epithelium efficiently regresses choroidal neovascularizationSemantic proximity Read ↗

The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.Semantic proximity Read ↗

Subretinal AAV delivery of RNAi-therapeutics targeting VEGFA reduces choroidal neovascularization in a large animal modelSemantic proximity Read ↗

In Vivo Applications of CRISPR-Based Genome Editing in the RetinaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.